Epoetin-β treatment in patients with cancer chemotherapy-induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromboembolic events

Effects of Epoetin Alfa on Hematologic Parameters and Quality of Life in Cancer Patients Receiving Nonplatinum Chemotherapy: Results of a Randomized, Double-Blind, Placebo-Controlled Trial

2001 • 996 citations

The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients

2004 • 862 citations

Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review.

2001 • 828 citations

Anemia as an independent prognostic factor for survival in patients with cancer

2001 • 698 citations

Maintaining Normal Hemoglobin Levels With Epoetin Alfa in Mainly Nonanemic Patients With Metastatic Breast Cancer Receiving First-Line Chemotherapy: A Survival Study

2005 • 667 citations

Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials

2009 • 572 citations

Double-Blind, Placebo-Controlled, Randomized Phase III Trial of Darbepoetin Alfa in Lung Cancer Patients Receiving Chemotherapy

2002 • 482 citations

Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy

2002 • 428 citations

Randomized, Double-Blind, Placebo-Controlled Trial of Erythropoietin in Non–Small-Cell Lung Cancer With Disease-Related Anemia

2007 • 427 citations

EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update

2006 • 401 citations

Erythropoietin or darbepoetin for patients with cancer

2012 • 382 citations

Blood Transfusions, Thrombosis, and Mortality in Hospitalized Patients With Cancer

2008 • 345 citations

Randomized, Double-Blind, Placebo-Controlled Trial of Recombinant Human Erythropoietin, Epoetin Beta, in Hematologic Malignancies

2002 • 312 citations

Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx

2001 • 264 citations

Erythropoietin regulates tumour growth of human malignancies

2003 • 257 citations

Recombinant Human Erythropoietin and Overall Survival in Cancer Patients: Results of a Comprehensive Meta-analysis

2005 • 240 citations

Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response

1995 • 226 citations

Darbepoetin Alfa for the Treatment of Anemia in Patients With Active Cancer Not Receiving Chemotherapy or Radiotherapy: Results of a Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

2008 • 217 citations

Recombinant human erythropoietin in transfusion-dependent anemic patients with multiple myeloma and non-Hodgkin's lymphoma--a randomized multicenter study. The European Study Group of Erythropoietin (Epoetin Beta) Treatment in Multiple Myeloma and Non-Hodgkin's Lymphoma

1996 • 210 citations

Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: a meta-analysis

2009 • 197 citations

Functional Significance of Erythropoietin Receptor Expression in Breast Cancer

2002 • 174 citations

A systematic review and economic evaluation of epoetin alfa, epoetin beta and darbepoetin alfa in anaemia associated with cancer, especially that attributable to cancer treatment

2007 • 171 citations

September 2007 Update on EORTC Guidelines and Anemia Management with Erythropoiesis-Stimulating Agents

2008 • 171 citations

Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models

2001 • 163 citations

Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma

2002 • 153 citations

Impact of epoetin β on quality of life in patients with malignant disease

2003 • 119 citations

Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: A randomized, controlled study

1998 • 110 citations

6LB Randomized study of the importance of Novel Erythropoiesis Stimulating Protein (Aranesp®) for the effect of radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC) – the Danish Head and Neck Cancer Group DAHANCA 10 randomized trial

2007 • 108 citations

Erythropoietin restores the anemia-induced reduction in cyclophosphamide cytotoxicity in rat tumors.

2001 • 108 citations

Effect of Once-Weekly Epoetin Beta on Survival in Patients With Metastatic Breast Cancer Receiving Anthracycline- and/or Taxane-Based Chemotherapy: Results of the Breast Cancer—Anemia and the Value of Erythropoietin (BRAVE) Study

2008 • 104 citations

Controlled multicentre study of the influence of subcutaneous recombinant human erythropoietin on anaemia and transfusion dependency in patients with ovarian carcinoma treated with platinum-based chemotherapy

1998 • 97 citations

Clinical factors and the risk of deep venous thrombosis

1975 • 86 citations

Randomized multicentre trial of the influence of recombinant human erythropoietin on intraoperative and postoperative transfusion need in anaemic patients undergoing right hemicolectomy for carcinoma

1998 • 80 citations

Erythropoietin restores the anemia-induced reduction in radiosensitivity of experimental human tumors in nude mice

2003 • 76 citations

Suspected Deep Vein Thrombosis

1982 • 74 citations

Effect of treatment with epoetin-β on survival, tumour progression and thromboembolic events in patients with cancer: an updated meta-analysis of 12 randomised controlled studies including 2301 patients

2008 • 73 citations

Impact of epoetin‐β on survival of patients with lymphoproliferative malignancies: long‐term follow up of a large randomized study*

2005 • 59 citations

Alternative splicing regulates activation-induced cytidine deaminase (AID): implications for suppression of AID mutagenic activity in normal and malignant B cells

2008 • 46 citations

Erythropoietin enhances radiation treatment efficacy in patients with pelvic malignancies. final results of a randomized phase III study

2001 • 44 citations

Effects of anemia correction with epoetin beta in patients receiving radiochemotherapy for advanced cervical cancer

2007 • 38 citations

Clinical impact of predictive assays for acute and late radiation morbidity.

1998 • 36 citations

Anaemia in cancer patients: pathophysiology, incidence and treatment

2005 • 34 citations

Increased autologous blood donation in rectal cancer by recombinant human erythropoietin (rhEPO)

1998 • 18 citations

Suspected deep vein thrombosis

1983 • 16 citations

What is the impact of antithrombotic therapy and risk factors on the frequency of thrombovascular events in patients with metastatic breast cancer receiving epoetin beta?

2009 • 14 citations

Recombinant Human Erythropoiesis Stimulating Agents in Cancer Patients: Individual Patient Data Meta-Analysis on Behalf of the EPO IPD Meta-Analysis Collaborative Group

2008 • 8 citations

Cited By (0)

No citing papers found in database